New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia

Mila Valsecchi, Andrea Lauterio, Roberto Crocchiolo, Riccardo De Carlis, Mariateresa Pugliano, Leonardo Centonze, Fabio Ferla, Matteo Zaniboni, Silvio Veronese, Gian Marco Podda, Luca Belli, Silvano Rossini, Luciano De Carlis, Roberto Fumagalli – 19 August 2021

Graft Survival and Segment Discards Among Split‐Liver and Reduced‐Size Transplantations in the United States From 2008 to 2018

John R. Montgomery, Alexandra Highet, Craig S. Brown, Seth A. Waits, Michael J. Englesbe, Christopher J. Sonnenday – 17 August 2021 – Split‐liver transplantation has allocation advantages over reduced‐size transplantation because of its ability to benefit 2 recipients.

Monitoring of Donor‐Derived Cell‐Free DNA by Short Tandem Repeats: Concentration of Total Cell‐Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation

Esther Fernández‐Galán, Celia Badenas, Constantino Fondevila, Wladimiro Jiménez, Miquel Navasa, Joan Anton Puig‐Butillé, Mercè Brunet – 17 August 2021 – Monitoring of graft function is essential during the first months after liver transplantation (LT), but current liver function tests (LFTs) lack the specificity and sensitivity to ensure an efficient diagnosis of acute rejection (AR). Recently, donor‐derived cell‐free DNA (ddcfDNA) has emerged as a noninvasive biomarker to assess graft integrity.

Subscribe to